Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Autoimmune Diseases × Valsartan × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urologic Diseases 1 Nephritis 1 Lymphoma, Non-Hodgkin 1 Kidney Diseases 1 Immune System Diseases 1 Glomerulonephritis, IGA 1 Glomerulonephritis 1 Cardiomyopathies 1 Autoimmune Diseases 1

Interventions

telitacicept 1 Valsartan 1 Pyridostigmine Bromide 1 Prednisone 1 Infliximab 1 Hydroxychloroquine 1 Etanercept 1 Adalimumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02765594 2017-09-20

HCQIgAN

Peking Union Medical College Hospital

Phase 4 Unknown

Autoimmune Diseases, Glomerulonephritis, Glomerulonephritis, IGA, Immune System Diseases, Kidney Diseases, Nephritis, Urologic Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡